Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Reliance Infratel files draft prospectus with Sebi
Anil Ambani group firm Reliance Communications (RCom) today said its telecom tower subsidiary Reliance Infratel has filed the draft prospectus for its initial public offer with market regulator Securities and Exchange Board of India (Sebi).

Local response to a global spread
Pandemics are global, but political calculation to confront them is decidedly local.

News of the day

TVS two-wheeler sales up 23%
TVS Motors today reported 23 per cent growth in total two-wheeler sales in November at 1,20,844 units against 98,402 units in the same month last year.
Small Business

Aurobindo back in black with Rs 103 cr profit

Aurobindo Pharma, Hyderabad-based manufacturer of generic and active pharmaceutical ingredients reported a net profit of Rs 103.2 crore for the quarter ended September 30, 2009, as against a net loss of Rs 38.4 crore during the corresponding period last year. Revenues were up 24.42 per cent to Rs 882.64 crore as compared with Rs 709.4 crore last year. - Aurobindo gets nod to market 2 more products in S Africa - Bharat Biotech"s "INDIRAB" vaccine sales doubles - Aurobindo gets US FDA nod - Suven Life"s drug discovery achieves milestone - Aurobindo Pharma receives Swissmedic approval - Aurobindo Pharma receives Swissmedic approval for cefepime for injection The company made a forex gain of Rs 3.7 crore during the quarter as against a loss of Rs 85.3 crore last year. Formulations sales increased 39.4 per cent to Rs 445.2 crore during the period as compared with Rs 319.3 crore, managing director K Nithyananda Reddy said in a release. Aurobindo had three abbreviated new drug applications and 16 dossier filings during the quarter.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009